Drugs / dexmedetomedine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable3 trials | ||||||
| — | NCT07480304 | Dec 2025 → Apr 2026 overdue | — | Dow University of Health Sciences | Enrolling by invitation | No outcome recorded |
| — | NCT02544906 | Sep 2015 → Oct 2016 | — | AlRefaey Kandeel | Unknown | No outcome recorded |
| — | NCT02531529 | Jan 2014 → Mar 2015 | — | Mansoura University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT04485273 Comparator | Jul 2019 → Jan 2021 | — | Sameh Fathy | Completed | No outcome recorded |
| — | NCT02708459 Comparator | Mar → Aug 2016 | — | AlRefaey Kandeel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dexmedetomedine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04485273 ↗ |
| Route | Other | “Dexmedetomedine 0.4 mg/kg plus Bupevecaine 0.25 20 ml boluses each 8 hours for 48 hours in surgically inserted TAP catheter” NCT02708459 ↗ |